XML 37 R26.htm IDEA: XBRL DOCUMENT v3.25.4
FAIR VALUE (Tables)
12 Months Ended
Dec. 31, 2025
FAIR VALUE  
Schedule of financial instruments measured at fair value on a recurring basis

  ​ ​ ​

Balance

  ​ ​ ​

Level 1

  ​ ​ ​

Level 2

  ​ ​ ​

Level 3

December 31, 2025

Cash and cash equivalents

$

13,196,033

$

13,196,033

$

$

Total assets

$

13,196,033

$

13,196,033

$

$

Warrant liability

$

226,000

$

$

$

226,000

Total liabilities

$

226,000

$

$

$

226,000

December 31, 2024

 

 

 

 

Cash and cash equivalents

$

23,288,607

$

23,288,607

$

$

Total assets

$

23,288,607

$

23,288,607

$

$

Warrant liability

$

1,718,000

$

$

$

1,718,000

Total liabilities

$

1,718,000

$

$

$

1,718,000

July 2024 Warrants  
FAIR VALUE  
Schedule of modified option pricing assumptions and assumptions used upon issuance

  ​ ​ ​

December 31, 

  ​ ​ ​

December 31, 

 

2025

2024

 

Volatility

 

110.00-117.00

%  

80.60-104.00

%

Risk-free interest rate

 

3.50-3.80

%  

3.50-4.20

%

Expected life (years)

 

3.30-4.10

 

0.50-4.80

Dividend

 

0

%  

0

%

September 2023 Warrants  
FAIR VALUE  
Schedule of modified option pricing assumptions and assumptions used upon issuance

  ​ ​ ​

December 31, 

  ​ ​ ​

December 31, 

 

2025

2024

Volatility

 

100.17-125.50

%  

105

%

Risk-free interest rate

 

3.55-3.89

%  

4.20-4.30

%

Expected life (years)

 

2.69-3.44

 

0.80-4.20

Dividend

 

0

%  

0

%

October 2022 Warrants  
FAIR VALUE  
Schedule of modified option pricing assumptions and assumptions used upon issuance

  ​ ​ ​

December 31, 

  ​ ​ ​

December 31, 

 

2025

2024

Volatility

 

147.20

%  

117.50

%

Risk-free interest rate

 

3.47

%  

4.27

%

Expected life (years)

 

1.80

 

2.80

Dividend

 

0

%  

0

%

Schedule of changes in the fair market value of the warrants

  ​ ​ ​

2025

  ​ ​ ​

2024

Beginning warrant fair value

$

1,718,000

$

13,131,691

Change in warrant fair value

(317,055)

(14,778,015)

Issuance of July 2024 inducement warrants

12,000,000

Settlement of warrants to equity

(1,174,945)

(7,410,000)

Exercise of October 2022 warrants

(1,225,676)

Ending warrant fair value

$

226,000

$

1,718,000